Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma.

Llovet, Josep M;Peña, Carol E A;Lathia, Chetan D;Shan, Michael;Borbath, Ivan;et.al.
(2012) Clinical Cancer Research —

Files

No attached file found for this publication.

Details

Authors
  • Llovet, Josep M
    Author
  • Peña, Carol E A
    Author
  • Lathia, Chetan D
    Author
  • Shan, Michael
    Author
  • Borbath, IvanUCLouvain
    Author
  • et. al.
Show more
Abstract
The angiogenesis biomarkers Ang2 and VEGF were independent predictors of survival in patients with advanced HCC. In contrast, none of the biomarkers tested significantly predicted response to sorafenib.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Llovet, J. M., Peña, C. E. A., Lathia, C. D., Shan, M., Meinhardt, G., Bruix, J., Borbath, I., & et al. (2012). Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.CCR-11-2175